Please login to the form below
prevention
This page shows the latest prevention news and features for those working in and with pharma, biotech and healthcare.
GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy
With world-class capabilities across prevention and treatment of disease, The new GSK is exceptionally well positioned to positively impact people’s health and to deliver strong performance and value to
Latest news
-
AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial
AstraZeneca’s long-acting COVID-19 antibody AZD7442 failed to hit the primary endpoint in a phase 3 prevention trial, the drugmaker announced today. . ... The STORM CHASER trial is a randomised placebo-controlled trial designed to evaluate the safety
-
Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
Last month, a US Centers for Disease Control and Prevention (CDC) advisory group said that further study of myocarditis in young adults who have received mRNA-based COVID-19 vaccines.
-
J&J's single-dose COVID-19 vaccine secures approval from the UK’s MHRA
However, following a review, US Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) recommended lifting the temporary pause on the jab, although regulators noted that women
-
FDA panel backs Provention Bio’s type 1 prevention drug teplizumab
A US Food and Drug Administration (FDA) panel has voted in favour of Provention Bio’s type 1 diabetes prevention drug teplizumab, setting it up for a potential approval in July.
-
Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab
In February, the European Medicines Agency (EMA) accepted Pfizer’s marketing authorisation application for 20vPnC for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine
AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial
Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
J&J's single-dose COVID-19 vaccine secures approval from the UK’s MHRA
FDA panel backs Provention Bio’s type 1 prevention drug teplizumab
Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab
More from news
Approximately 5 fully matching, plus 844 partially matching documents found.
Latest Intelligence
-
Medicinal data – what’s next for IDMP?
monitoring, managing any side effects, and in supporting regulatory preventions and interventions.
-
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
At AstraZeneca, we are working to advance solutions across the full continuum of renal care, from prevention and protection before a CKD diagnosis, to help slowing disease progression and addressing complications
-
Three ways AI will change healthcare in the next decade
Introducing the predictive power of AI. They say that prevention is better than cure.
-
Treatment and prevention of cardiovascular disease
Many advances in the treatment and prevention of cardiovascular disease have been made over the past few decades including. ... Intervention Trial) with a highly purified omega-3 fatty acid signalled a promising development in cardiovascular disease
-
Growing evidence supports the important role of biosimilars in healthcare
These findings align with the recent NCCN recommendations for FN prevention, which have expanded to those receiving intermediate-risk regimens (in addition to those at high risk) as a response to
Medicinal data – what’s next for IDMP?
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
Three ways AI will change healthcare in the next decade
Treatment and prevention of cardiovascular disease
Growing evidence supports the important role of biosimilars in healthcare
More from intelligence
Approximately 2 fully matching, plus 97 partially matching documents found.
Latest appointments
-
Four Health announces a pair of internal promotions
role of the NHS in public health and prevention medicine.
-
New hires at bluebird bio, BioNTech and Provention Bio
In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy
-
Destiny Pharma appoints new CEO
As we move forward, Neil’s extensive leadership experience in clinical stage biopharmaceutical companies will be investigating XF-73 as a potential first-in-class drug for the prevention of
-
New health ministers and re-appointments after reshuffle
resistance, cancer, dementia, diabetes as well as issues around vaccination and the prevention of long-term conditions.
-
Merck names head of strategic communications
Prior to this role, she served as director of the US Centers for Disease Control and Prevention from 2002 and was director of the Division of Healthcare Quality Promotion before that.
Four Health announces a pair of internal promotions
New hires at bluebird bio, BioNTech and Provention Bio
Destiny Pharma appoints new CEO
New health ministers and re-appointments after reshuffle
Merck names head of strategic communications
More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
Remote Patient Monitoring
7. Furthermore, data can inform clinical research into drug discovery and disease prevention, facilitating faster vaccine development and new treatments, not just for COVID-19, but also for other diseases.
-
Improving Public Health Through Telemedicine
Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies should be funded by healthcare professionals
-
Understanding the role of provider collaboratives
It is therefore essential for industry to think widely about illness prevention and management, to ensure that its products are aligned with optimal care pathways and to define how they can
-
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
It will mark the first nationwide effort to talk specifically about opioid overdose prevention and naloxone, a drug that can reverse an opioid overdose – caused by drugs like heroin.
-
Is communication killing the COVID-19 vaccine’s chance at success?
Except in this case, the inner workings of how and why things like vaccinations and prevention work shouldn’t be on a need-to-know basis – we all need to know.
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
More from PMHub
Approximately 2 fully matching, plus 58 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
-
Planner
-
Salary TBC
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
-
Senior Account Manager
-
Salary TBC
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Court rules on AZ and EU’s COVID-19 vaccine dispute
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- BMS’s oral AML therapy Onureg receives EU approval
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
- Breaking Down the Wall: Blockchain in Healthcare and Pharma
- Building Better Patient Advocates Through Authentic Partnerships
- Virgo Health makes two hires to leadership team
- Hanover Health appoints Aleksandra Lugović as an associate director
- GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy
- Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
- Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- Diversity and inclusion in clinical trials
- BMS’ CAR T therapy Breyanzi shows benefit in B-cell lymphoma study
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Numbers, navigation, and narratives: digital storytelling in medical communications
- Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
- Is this common data mistake killing your digital patient recruitment?
- Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
- The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
- By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
